Epidemiology of Congenital Neutropenia

Hematology/Oncology Clinics of North America

Volumn 27, Issue 1, 2013, Pages 1-17

  Donadieu, Jean ^a   Beaupain, Blandine ^a   Mahlaoui, Nizar ^b   Bellanné Chantelot, Christine ^c  

^a ARMAND TROUSSEAU HOSPITAL   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Birth incidence; Congenital neutropenia; Epidemiology; Prevalence

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR;

BONE MARROW DEPRESSION; CLINICAL FEATURE; DRUG SAFETY; GENETIC DISORDER; GENETIC EPIDEMIOLOGY; GLYCOGEN STORAGE DISEASE TYPE 1; HUMAN; INFECTIOUS CANINE HEPATITIS; LEUKEMIA; MALIGNANT TRANSFORMATION; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SEVERE CONGENITAL NEUTROPENIA; SOMATIC MUTATION; SURVIVAL;

CELL TRANSFORMATION, NEOPLASTIC; HUMANS; INCIDENCE; MORBIDITY; NEUTROPENIA; PREVALENCE; PROGNOSIS; REGISTRIES; RISK FACTORS;

EID: 84872733644     PISSN: 08898588     EISSN: 15581977     Source Type: Journal    
DOI: 10.1016/j.hoc.2012.11.003     Document Type: Review

References (84)

1. Pincus S.H., Boxer L.A., Stossel T.P. Chronic neutropenia in childhood. Analysis of 16 cases and a review of the literature. Am J Med 1976, 61(6):849-861.
2. Kostmann R. Hereditär reticulos - en ny systemsjukdom. Svenska Läkartideningen 1950, 47:2861-2868.
3. Kostmann R. Infantile genetic agranulocytosis; agranulocytosis infantilis hereditaria. Acta Paediatr Suppl 1956, 45(Suppl 105):1-78.
4. Klein C., Grudzien M., Appaswamy G., et al. HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease). Nat Genet 2007, 39(1):86-92.
5. Carlsson G., van't H.I., Melin M., et al. Central nervous system involvement in severe congenital neutropenia: neurological and neuropsychological abnormalities associated with specific HAX1 mutations. J Intern Med 2008, 264(4):388-400.
6. Palmer S.E., Stephens K., Dale D.C. Genetics, phenotype, and natural history of autosomal dominant cyclic hematopoiesis. Am J Med Genet 1996, 66(4):413-422.
7. Dale D.C., Cottle T.E., Fier C.J., et al. Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry. Am J Hematol 2003, 72(2):82-93.
8. Freedman M.H., Bonilla M.A., Fier C., et al. Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy. Blood 2000, 96(2):429-436.
9. Horwitz M., Benson K.F., Person R.E., et al. Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis. Nat Genet 1999, 23(4):433-436.
10. Dale D.C., Person R.E., Bolyard A.A., et al. Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood 2000, 96(7):2317-2322.
11. Dale D.C., Bolyard A.A., Schwinzer B.G., et al. The Severe Chronic Neutropenia International Registry: 10-year follow-up report. Support Cancer Ther 2006, 3(4):220-231.
12. Donadieu J., Leblanc T., Bader M.B., et al. Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group. Haematologica 2005, 90(1):45-53.
13. Notarangelo L.D., Fischer A., Geha R.S., et al. Primary immunodeficiencies: 2009 update. J Allergy Clin Immunol 2009, 124(6):1161-1178.
14. Donadieu J., Fenneteau O., Beaupain B., et al. Congenital neutropenia: diagnosis, molecular bases and patient management. Orphanet J Rare Dis 2011, 6(1):26.
15. Hsieh M.M., Everhart J.E., Byrd-Holt D.D., et al. Prevalence of neutropenia in the U.S. population: age, sex, smoking status, and ethnic differences. Ann Intern Med 2007, 146(7):486-492.
16. Denic S., Showqi S., Klein C., et al. Prevalence, phenotype and inheritance of benign neutropenia in Arabs. BMC Blood Disord 2009, 9:3.
17. Papadaki H.A., Xylouri I., Coulocheri S., et al. Prevalence of chronic idiopathic neutropenia of adults among an apparently healthy population living on the island of Crete. Ann Hematol 1999, 78(7):293-297.
18. Grann V.R., Ziv E., Joseph C.K., et al. Duffy (Fy), DARC, and neutropenia among women from the United States, Europe and the Caribbean. Br J Haematol 2008, 143(2):288-293.
19. Dreyer N.A., Garner S. Registries for robust evidence. JAMA 2009, 302(7):790-791.
20. Available at: Accessed November 29, 2012. http://nestor.orpha.net/EUCERD/upload/file/RDTFRegistriesrev2011.pdf.
21. Available at: Accessed November 29, 2012. http://rarediseases.info.nih.gov/.
22. Available at: Accessed November 29, 2012. https://www.peds.ufl.edu/barthsyndromeregistry/scientist.htm.
23. Cipolli M., D'Orazio C., Delmarco A., et al. Shwachman's syndrome: pathomorphosis and long-term outcome. J Pediatr Gastroenterol Nutr 1999, 29(3):265-272.
24. Atkins D., Eccles M., Flottorp S., et al. Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group. BMC Health Serv Res 2004, 4(1):38.
25. Guyatt G.H., Oxman A.D., Sultan S., et al. GRADE guidelines: 9. Rating up the quality of evidence. J Clin Epidemiol 2011, 64(12):1311-1316.
26. Tamary H., Nishri D., Yacobovich J., et al. Frequency and natural history of inherited bone marrow failure syndromes: the Israeli Inherited Bone Marrow Failure Registry. Haematologica 2010, 95(8):1300-1307.
27. Tsangaris E., Klaassen R., Fernandez C.V., et al. Genetic analysis of inherited bone marrow failure syndromes from one prospective, comprehensive and population-based cohort and identification of novel mutations. J Med Genet 2011, 48(9):618-628.
28. Carlsson G., Fasth A., Berglof E., et al. Incidence of severe congenital neutropenia in Sweden and risk of evolution to myelodysplastic syndrome/leukaemia. Br J Haematol 2012, 158(3):363-369.
29. Donadieu J., Fenneteau O., Beaupain B., et al. Classification and risk factors of hematological complications in a French national cohort of 102 patients with Shwachman-Diamond syndrome. Haematologica 2012, 97(9):1312-1319.
30. The French national registry of primary immunodeficiency diseases. Clin Immunol 2010, 135(2):264-272.
31. Available at: Accessed November 29, 2012. http://www.esid.org/registry-number-of-patients.
32. Rezaei N., Aghamohammadi A., Moin M., et al. Frequency and clinical manifestations of patients with primary immunodeficiency disorders in Iran: update from the Iranian Primary Immunodeficiency Registry. J Clin Immunol 2006, 26(6):519-532.
33. Rezaei N., Moin M., Pourpak Z., et al. The clinical, immunohematological, and molecular study of Iranian patients with severe congenital neutropenia. J Clin Immunol 2007, 27(5):525-533.
34. Boocock G.R., Morrison J.A., Popovic M., et al. Mutations in SBDS are associated with Shwachman-Diamond syndrome. Nat Genet 2003, 33(1):97-101.
35. Reimann H.A., deBerardinis C.T. Periodic (cyclic) neutropenia, an entity; a collection of 16 cases. Blood 1949, 4(10):1109-1116.
36. Stahlie T.D. Chronic benign neutropenia in infancy and early childhood; report of a case with a review of the literature. J Pediatr 1956, 48(6):710-721.
37. Kostmann R. Infantile genetic agranulocytosis. Acta Paediatr Scand 1975, 64:362-64368.
38. Bellanne-Chantelot C., Clauin S., Leblanc T., et al. Mutations in the ELA2 gene correlate with more severe expression of neutropenia: a study of 81 patients from the French Neutropenia Register. Blood 2004, 103(11):4119-4125.
39. Beaussant Cohen S., Fenneteau O., Plouvier E., et al. Description and outcome of a cohort of 8 patients with WHIM syndrome from the French Severe Chronic Neutropenia Registry. Orphanet J Rare Dis 2012, 7(1):71.
40. Roe T.F., Coates T.D., Thomas D.W., et al. Brief report: treatment of chronic inflammatory bowel disease in glycogen storage disease type Ib with colony-stimulating factors. N Engl J Med 1992, 326(25):1666-1669.
41. Abdollahpour H., Appaswamy G., Kotlarz D., et al. The phenotype of human STK4 deficiency. Blood 2012, 119(15):3450-3457.
42. Hsu A.P., Sampaio E.P., Khan J., et al. Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood 2011, 118(10):2653-2655.
43. Rosenberg P.S., Alter B.P., Bolyard A.A., et al. The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy. Blood 2006, 107(12):4628-4635.
44. Carlsson G., Wahlin Y.B., Johansson A., et al. Periodontal disease in patients from the original Kostmann family with severe congenital neutropenia. J Periodontol 2006, 77(4):744-751.
45. Dale D.C. The discovery, development and clinical applications of granulocyte colony-stimulating factor. Trans Am Clin Climatol Assoc 1998, 109:27-36.
46. Bonilla M.A., Gillio A.P., Ruggeiro M., et al. Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. N Engl J Med 1989, 320(24):1574-1580.
47. Dale D.C., Bonilla M.A., Davis M.W., et al. A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood 1993, 81(10):2496-2502.
48. De Vries A., Peketh L., Joshua H. Leukaemia and agranulocytosis in a member of a family with hereditary leukopenia. Acta Med Orient 1958, 17:26-32.
49. Gilman P.A., Jackson D.P., Guild H.G. Congenital agranulocytosis: prolonged survival and terminal acute leukemia. Blood 1970, 36:576-585.
50. Rosen R., Kang S. Congenital agranulocytosis terminating in acute myelomonocytic leukemia. J Pediatr 1979, 94:406-408.
51. Kojima S., Ohara A., Tsuchida M., et al. Risk factors for evolution of acquired aplastic anemia into myelodysplastic syndrome and acute myeloid leukemia after immunosuppressive therapy in children. Blood 2002, 100(3):786-790.
52. Socie G., Mary J.Y., Schrezenmeier H., et al. Granulocyte-stimulating factor and severe aplastic anemia: a survey by the European Group for Blood and Marrow Transplantation (EBMT). Blood 2007, 109(7):2794-2796.
53. Hershman D., Neugut A.I., Jacobson J.S., et al. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy. J Natl Cancer Inst 2007, 99(3):196-205.
54. Le Deley M.C., Leblanc T., Shamsaldin A., et al. Risk of secondary leukemia after a solid tumor in childhood according to the dose of epipodophyllotoxins and anthracyclines: a case-control study by the Société Française d'Oncologie Pédiatrique. J Clin Oncol 2003, 21(6):1074-1081.
55. Smith R.E., Bryant J., DeCillis A., et al. Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer: the National Surgical Adjuvant Breast and Bowel Project Experience. J Clin Oncol 2003, 21(7):1195-1204.
56. Rosenberg P.S., Alter B.P., Link D.C., et al. Neutrophil elastase mutations and risk of leukaemia in severe congenital neutropenia. Br J Haematol 2008, 140(2):210-213.
57. Yetgin S., Olcay L., Koc A., et al. Transformation of severe congenital neutropenia to early acute lymphoblastic leukemia in a patient with HAX1 mutation and without G-CSF administration or receptor mutation. Leukemia 2008, 22(9):1797.
58. Beel K., Vandenberghe P. G-CSF receptor (CSF3R) mutations in X-linked neutropenia evolving to acute myeloid leukemia or myelodysplasia. Haematologica 2009, 94(10):1449-1452.
59. Dror Y. Shwachman-Diamond syndrome. Pediatr Blood Cancer 2005, 45(7):892-901.
60. Stoll C., Alembik Y., Lutz P. A syndrome of facial dysmorphia, birth defects, myelodysplasia and immunodeficiency in three sibs of consanguineous parents. Genet Couns 1994, 5(2):161-165.
61. Schroeder T., Hildebrandt B., Mayatepek E., et al. A patient with glycogen storage disease type Ib presenting with acute myeloid leukemia (AML) bearing monosomy 7 and translocation t(3;8)(q26;q24) after 14 years of treatment with granulocyte colony-stimulating factor (G-CSF): a case report. J Med Case Rep 2008, 2:319.
62. Pinsk M., Burzynski J., Yhap M., et al. Acute myelogenous leukemia and glycogen storage disease 1b. J Pediatr Hematol Oncol 2002, 24(9):756-758.
63. Ostergaard P., Simpson M.A., Connell F.C., et al. Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome). Nat Genet 2011, 43(10):929-931.
64. Cleary P.D., Morrissey G., Yver A., et al. The effects of rG-CSF on health-related quality of life in children with congenital agranulocytosis. Qual Life Res 1994, 3(5):307-315.
65. Fazio M.T., Glaspy J.A. The impact of granulocyte colony-stimulating factor on quality of life in patients with severe chronic neutropenia. Oncol Nurs Forum 1991, 18(8):1411-1414.
66. Ward A.C., van Aesch Y.M., Gits J., et al. Novel point mutation in the extracellular domain of the granulocyte colony-stimulating factor (G-CSF) receptor in a case of severe congenital neutropenia hyporesponsive to G-CSF treatment. J Exp Med 1999, 190(4):497-507.
67. Person R.E., Li F.Q., Duan Z., et al. Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2. Nat Genet 2003, 34(3):308-312.
68. Ancliff P.J., Blundell M.P., Cory G.O., et al. Two novel activating mutations in the Wiskott-Aldrich syndrome protein result in congenital neutropenia. Blood 2006, 108(7):2182-2189.
69. Devriendt K., Kim A.S., Mathijs G., et al. Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia. Nat Genet 2001, 27(3):313-317.
70. Hernandez P.A., Gorlin R.J., Lukens J.N., et al. Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease. Nat Genet 2003, 34(1):70-74.
71. Carlsson G., Fasth A. Infantile genetic agranulocytosis, morbus Kostmann: presentation of six cases from the original " Kostmann family" and a review. Acta Paediatr 2001, 90(7):757-764.
72. Faiyaz-Ul-Haque M., Al-Jefri A., Al-Dayel F., et al. A novel HAX1 gene mutation in severe congenital neutropenia (SCN) associated with neurological manifestations. Eur J Pediatr 2010, 169(6):661-666.
73. Ishikawa N., Okada S., Miki M., et al. Neurodevelopmental abnormalities associated with severe congenital neutropenia due to the R86X mutation in the HAX1 gene. J Med Genet 2008, 45(12):802-807.
74. Boztug K., Appaswamy G., Ashikov A., et al. A syndrome with congenital neutropenia and mutations in G6PC3. N Engl J Med 2009, 360(1):32-43.
75. Barth P.G., Wanders R.J., Vreken P., et al. X-linked cardioskeletal myopathy and neutropenia (Barth syndrome) (MIM 302060). J Inherit Metab Dis 1999, 22(4):555-567.
76. Huizing M., Scher C.D., Strovel E., et al. Nonsense mutations in ADTB3A cause complete deficiency of the beta3A subunit of adaptor complex-3 and severe Hermansky-Pudlak syndrome type 2. Pediatr Res 2002, 51(2):150-158.
77. Bohn G., Allroth A., Brandes G., et al. A novel human primary immunodeficiency syndrome caused by deficiency of the endosomal adaptor protein p14. Nat Med 2007, 13(1):38-45.
78. Mostefai R., Morice-Picard F., Boralevi F., et al. Poikiloderma with neutropenia, Clericuzio type, in a family from Morocco. Am J Med Genet A 2008, 146A(21):2762-2769.
79. Volpi L., Roversi G., Colombo E.A., et al. Targeted next-generation sequencing appoints c16orf57 as Clericuzio-type poikiloderma with neutropenia gene. Am J Hum Genet 2010, 86(1):72-76.
80. Veiga-da-Cunha M., Gerin I., Chen Y.T., et al. The putative glucose 6-phosphate translocase gene is mutated in essentially all cases of glycogen storage disease type I non-a. Eur J Hum Genet 1999, 7(6):717-723.
81. Kolehmainen J., Black G.C., Saarinen A., et al. Cohen syndrome is caused by mutations in a novel gene, COH1, encoding a transmembrane protein with a presumed role in vesicle-mediated sorting and intracellular protein transport. Am J Hum Genet 2003, 72(6):1359-1369.
82. Xia J., Bolyard A.A., Rodger E., et al. Prevalence of mutations in ELANE, GFI1, HAX1, SBDS, WAS and G6PC3 in patients with severe congenital neutropenia. Br J Haematol 2009, 147(4):535-542.
83. Tassone L., Notarangelo L.D., Bonomi V., et al. Clinical and genetic diagnosis of warts, hypogammaglobulinemia, infections, and myelokathexis syndrome in 10 patients. J Allergy Clin Immunol 2009, 123(5):1170-1173. 1173.e1-3.
84. Boztug K., Rosenberg P.S., Dorda M., et al. Extended spectrum of human glucose-6-phosphatase catalytic subunit 3 deficiency: novel genotypes and phenotypic variability in severe congenital neutropenia. J Pediatr 2012, 160(4):679-683.